U.S. Pharmacopeial Convention

  • Content
  • Navigation
  • Calendar
  • FAQs
  • Support
  • Buy Reference Standards
Cart
Store Logout | Direct Item Entry

Languages

  • English
  • Español
  • 简体中文
  • Português

Navigation

  • About
    • USP Offices
    • Leadership
    • History & Information Center
    • Legal Recognition
    • Quality Policy & ISO Accreditation
    • Public Policy
    • Careers
  • USP–NF
    • Official Text
    • Pharmacopeial Forum
    • Key Issues
    • Development Process
    • Notices
    • Harmonization
    • Pending Monograph Program
  • Dietary Supplements
    • Dietary Supplements Compendium
    • Development Process
    • Reference Standards
    • Verification Services
    • Resources
  • Food
    • Food Chemicals Codex
    • FCC Forum
    • Food Ingredient Reference Materials
    • Food Fraud Database
    • Development Process
    • Notices
  • Reference Standards
    • Reference Standards Catalog
    • New Reference Standards
    • Development Process
    • Use and Storage
    • Safety Data Sheets
  • Global
    • Global Activities
    • Herbal Medicines Compendium
    • Global Health Programs
    • Outreach and Exchange Programs
  • Meetings & Courses
    • Meetings Center Rental
    • Calendar
    • Stakeholder Forums
    • Workshops
    • Courses
    • User Forums
  • News
    • Quality Matters Blog
    • Press Releases
    • News Coverage
    • Newsletters
  • Store
    • Products
    • Services and Resources
  • Translate this page
    • English
    • Español
    • 简体中文
    • Português
  • Email Page
  • Print
You are here: Home > Reference Standards > New Reference Standards

New Reference Standards

Newly Released Reference Standards

First time in USP Catalog Reference Standards. Click a reference standards for more details.

Access ordering information, find your account manager, and download our comprehensive list of available reference standards, updated daily, here.

  • Brimonidine Tartrate (250 mg)
  • Brimonidine Related Compound E (15 mg) (2-(5-Bromoquinoxalin-6-yl)guanidine
  • Chia Seed Oil (3 x 1 g)
  • Epinastine Hydrochloride (250 mg)
  • Megestrol Acetate Related Compound D (20 mg) (6-Methylene-3,20-dioxopregn-4-en-17-yl acetate)
  • Megestrol Acetate Related Compound H (20 mg)
  • Methylnaltrexone Peak Identification Mixture CII (10 mg) (Methylnaltrexone Bromide containing about 0.1% methylnaltrexone related compound A)
  • Methyl Ricinoleate (100 mg)
  • Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
  • Naproxen Related Compound G (50 mg) ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
  • Raltegravir Related Compound E (20 mg) (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide)
  • D-Salicin (150 mg)
  • Salix Species Bark Dry Extract (1 g)
  • New Reference Standards Notification
  • How to Read Listings
  • Reference Standards Under Development
  • Suggest a Reference Standard

Contact Information

  • Reference Standards Technical Support: rstech@usp.org | +1-301-816-8129
  • Customer Service: custsvc@usp.org | 1-800-227-8772 (U.S. & Canada); 00-800-4875-5555 (select Europe) | +1-301-881-0666 (General)

Related Resources

  • Reference Standards FAQs
  • Dissolution Performance Verification Testing
  • Compendial Tools
  • USP Catalog Archives
  • USP Monthly E-mail Notices
  • Currency Change Request (PDF)
  • Credit Application (PDF)
  • USP Authorized Distributors (PDF)
  • Terms and Conditions of Sale (PDF)

Follow Us On:

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • USP Quality Matters Blog
  • RSS
  • Contact Us
  • Purchasing Terms
  • Site Map
  • Privacy Policy
  • Legal Policies
  • Code of Ethics
  • Cookies Policy

Copyright 2017 The United States Pharmacopeial Convention